Hard-to-find patient samples for research – simplified at last A huge benefit to investigators in drug discovery and diagnostic development is the ability to test promising leads on actual patient samples. But for many researchers, gaining access to patient samples, such as serum from a 50- to 65-year old male tested for C-reactive protein, is […]
Combination of HaloTag® and HTRF® technologies provides a new, flexible tool for cell surface receptor heterodimerization Bagnols-sur-Cèze, France – Cisbio Bioassays (www.htrf.com), a member of IBA group and global developer of HTRF® (Homogeneous Time-Resolved Fluorescence) technology and services used in assay development and drug screening, announced today that Promega Corporation’s HaloTag® technology is available for […]
Burlingame, CA – Epitomics, Inc. today announced that The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has chosen the company to distribute a panel of LRRK2 monoclonal antibodies that were developed under an agreement between the two parties. Under a special arrangement the antibodies are being provided at low cost to the entire PD […]
· Consolidation of Acquisitions, Improved Operations intended to reduce annualized operating expenses by more than $4 million. · Company Cash, Cash Equivalents and Short-Term Investments approximated $34 million at July 31, 2010, same as three months earlier. · Fiscal 2010 Fourth Quarter Year over Year Revenue Increase Expected, Gross Margins Consistent; exclusive of one-time and […]
Paris (france) and New Delhi (india) – cellectis bioresearch, the specialist in Genome customization and subsidiary of cellectis (alternext: alcls), and helix bioservice & consultants pvt ltd (helix biocon), today announced that they will join forces for the promotion of cellectis bioresearch’s meganuclease-based products and services in india. helix biocon is a young company comprised […]
Evaluating iCell Cardiomyocytes on the xCELLigence System Madison, Wisc. – Cellular Dynamics International (CDI) announced today their partnership with ACEA Biosciences to bring early and accurate prediction of potential cardiotoxic side effects to the drug discovery process. The partnership combines CDI’s induced pluripotent stem cell (iPSC)-derived heart cells, iCell™ Cardiomyocytes, with the xCELLigence™ RTCA System. […]
New Dye’s Emission Spectrum Closely Resembles Pacific Orange BREA, Calif. – Beckman Coulter, Inc. introduces Krome Orange, a novel violet-excited organic dye that expands the range of available choices and dye sensitivity limits for violet lasers. Common gating markers can be easily transferred to this fluorochrome, freeing other channels for use with more esoteric markers […]
SAN DIEGO – Cytori Therapeutics, Inc. (NASDAQ:CYTX) has extended the term and modified the focus of its current distribution agreement with GE Healthcare. GE Healthcare’s sales rights allow its sales force to sell Cytori technology in the research markets in select European markets and the US. In turn, Cytori has co-exclusive sales rights into the […]
Today Bioo Scientific launched the MaxDiscovery™ Aspartate Transaminase (AST) and Lactate Dehydrogenase (LDH) Color Endpoint Assays for in vivo toxicity analysis. Austin, TX – Bioo Scientific announced the availability of the MaxDiscovery™ Aspartate Transaminase (AST) and Lactate Dehydrogenase (LDH) Color Endpoint Assays which use a proprietary, innovative technology for visible detection of in vivo toxicity […]
Enhanced specificity, affinity and reproducibility Naarden, The Netherlands – BAC, the leading provider of antibody-based affinity purification technologies, announces the launch of CaptureSelect® HumanPlasma14 for highly specific, reproducible depletion of the 14 most abundant proteins from human blood plasma or serum. HumanPlasma14 is designed for single-step, single-use depletion of more than 99% of the abundant […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
